| Mark H Backlund, MD | |
|
1103 Cleveland Ave, Mount Vernon, WA 98273-4215 | |
| (360) 336-6868 | |
| (360) 336-6866 |
| Full Name | Mark H Backlund |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1103 Cleveland Ave, Mount Vernon, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306883152 | NPI | - | NPPES |
| 1031368 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD00015319 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark H Backlund, MD 1103 Cleveland Ave, Mount Vernon, WA 98273-4215 Ph: (360) 336-6868 | Mark H Backlund, MD 1103 Cleveland Ave, Mount Vernon, WA 98273-4215 Ph: (360) 336-6868 |
News Archive
Glioblastoma is one of the most ominous brain tumors. Despite aggressive surgery, radiation and chemotherapy the outcome of this disease is almost always fatal.
March 18-24, 2012 will mark the 50th Anniversary of National Poison Prevention Week (NPPW), first established by Congress in September 1961. As one of the longest continuously running, health and safety campaigns in the United States, the key goal of NPPW is to create national awareness about the risk of injury or death due to poisoning.
Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
› Verified 6 days ago
Rozina Lakhani, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1103 Cleveland Avenue, Mount Vernon, WA 98273 Phone: 360-336-6868 Fax: 360-336-6866 | |
Dr. Patti Jo Brettell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 336-042-8259 Fax: 360-428-2560 | |
Nathan Tolley, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-2422 Fax: 360-814-8215 | |
Amir C Mazhari, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2550 Fax: 360-428-6402 | |
Dr. Vance E. Sherman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1415 E Kincaid St, Psychiatry Dept, Mount Vernon, WA 98274 Phone: 360-424-2511 Fax: 360-424-2522 | |
Kathryn Anne Roberts, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2550 Fax: 360-428-6402 |